Clinical Trial Update: Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Patupilone was studied in a Phase 2 trial for advanced/metastatic hepatocellular carcinoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Patupilone (epothilone B)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED